Patents by Inventor Zongbin LI

Zongbin LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORM OR AMORPHOUS FORM OF MACROCYCLIC COMPOUND OR SALT OR SOLVATE THEREOF
    Publication number: 20250109134
    Abstract: Disclosed are a crystalline form or an amorphous form of a macrocyclic compound or a salt or solvate thereof, as well as a preparation method therefor and an application thereof. The structure of the macrocyclic compound is represented by formula I.
    Type: Application
    Filed: January 29, 2023
    Publication date: April 3, 2025
    Inventors: Yanqiong LIN, Jianfeng WEN, Jianpeng FENG, Weidong LI, Chuanshen WANG, Zongbin LI
  • THE CRYSTALLINE FORMS OR AMORPHOUS FORMS OF BISDIAZABICYCLIC COMPOUNDS OR SALTS THEREOF
    Publication number: 20230257384
    Abstract: Crystallines form or amorphous forms of bisdiazabicyclic compounds or salts thereof for the treatment and/or prevention of diseases or disorders related to hepatitis virus, and a preparation method and application thereof are provided. The crystalline forms or amorphous forms involved provide important reference value for the development and utilization of drugs in the future.
    Type: Application
    Filed: July 16, 2021
    Publication date: August 17, 2023
    Inventors: Jianfeng Wen, Yanqiong Lin, Tianzhu Wu, Minmin Cai, Zongbin Li, Weidong Li
  • AMORPHOUS FORM OR CRYSTALLINE FORM OF 2-INDOLINOLINOLOLYLSPIRONONE COMPOUNDS OR THEIR SALTS, SOLVENT COMPLEXES
    Publication number: 20230064976
    Abstract: Amorphous form or crystalline form of a 2-indolinolinololylspironone compound or its salt and solvate used as an MDM2 inhibitor, a preparation method and an application thereof. The amorphous form or crystalline form of the invention has good stability and is of great value for drug development, preparation development and production.
    Type: Application
    Filed: January 22, 2021
    Publication date: March 2, 2023
    Applicants: ASCENTAGE PHARMA (SUZHOU) CO., LTD., ASCENTAGE PHARMA GROUP CORP LIMITED
    Inventors: Jianfeng WEN, Jianpeng FENG, Tianzhu WU, Weidong LI, Yanqiong LIN, Zongbin LI
  • SALT AND CRYSTAL FORM OF STEROID DERIVATIVE REGULATOR
    Publication number: 20220275020
    Abstract: The present invention relates to a steroid derivative regulator, in particular to a compound of formula (I), a salt and crystal form thereof, a preparation method therefor, a pharmaceutical composition containing a therapeutically effective amount of the crystal form, and an application thereof as a GABAA receptor regulator in treatment of depression, convulsions, Parkinsonism and nervous system diseases.
    Type: Application
    Filed: August 5, 2020
    Publication date: September 1, 2022
    Inventors: Zongbin LI, Yuanzhuo KUANG, Linsong GUO
  • Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method therefor
    Patent number: 10626107
    Abstract: A crystal form and a salt type of a substituted 2-hydro-pyrazole derivative, preparation method therefor, and use of the crystal form and the salt type in preparation of a medicament for treating cancers such as breast cancer, lung cancer and the like.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: April 21, 2020
    Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Charles Z. Ding, Shuhui Chen, Lihong Hu, Zhaobing Xu, Yingchun Liu, Bingjie Ren, Weidong Li, Zongbin Li, Rui Zhao, Xiquan Zhang
  • Pyrido[1,2-A]pyrimidone analog, crystal form thereof, intermediate thereof and preparation method therefor
    Patent number: 10479789
    Abstract: Disclosed in the present invention are a crystalline Form of pyrido[1,2-a]pyrimidone analog, a preparation method therefor and an intermediate thereof.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: November 19, 2019
    Assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Inventors: Tao Yu, Ning Li, Lingwei Kong, Peipei Jiang, Yong Wang, Zhemin Rong, Changjun Wang, Feng Guo, Zongbin Li, Zheng Wang, Jiahu Wu, Chengde Wu
  • CRYSTAL AND SALT OF NITROIMIDAZOLE, AND MANUFACTURING METHOD THEREOF
    Publication number: 20190276475
    Abstract: The present invention discloses a crystal form and salt of a nitroimidazole compound, and a manufacturing method thereof. The invention further comprises an application of the crystal form and salt in preparing a pharmaceutical product for preventing and treating an infection caused by Mycobacterium tuberculosis or another microbe.
    Type: Application
    Filed: July 21, 2017
    Publication date: September 12, 2019
    Applicant: Medshine Discovery Inc.
    Inventors: Wei LUO, Charles Z. DING, Zhigang HUANG, Yinghu HU, Zongbin LI, Qingqing LU
  • CRYSTAL FORM, SALT TYPE OF SUBSTITUTED 2-HYDRO-PYRAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR
    Publication number: 20190194168
    Abstract: A crystal form and a salt type of a substituted 2-hydro-pyrazole derivative, preparation method therefor, and use of the crystal form and the salt type in preparation of a medicament for treating cancers such as breast cancer, lung cancer and the like.
    Type: Application
    Filed: September 8, 2017
    Publication date: June 27, 2019
    Inventors: Charles Z. Ding, Shuhui Chen, Lihong Hu, Zhaobing Xu, Yingchun Liu, Bingjie Ren, Weidong Li, Zongbin Li, Rui Zhao, Xiquan Zhang
  • Crystal form, preparation method and intermediate of dihydropyrido ring compound
    Patent number: 10253030
    Abstract: Disclosed in the present disclosure are a crystal form of a dihydropyrido ring compound, and preparation method and intermediate thereof.
    Type: Grant
    Filed: November 2, 2016
    Date of Patent: April 9, 2019
    Assignee: QILU PHARMACEUTICAL CO., LTD.
    Inventors: Haiying He, Kai Zhou, Xiaolin Li, Xiaofei Wang, Dakun Qin, Xingxing Wang, Feifei Yang, Zheng Wang, Zongbin Li
  • Salt form and crystal form of 1,2,5-thiadiazolidin-1,1-dioxide, preparation method thereof and intermediate
    Patent number: 10227339
    Abstract: The present invention discloses a salt form, crystal form and intermediate of the compound 1, and preparation method thereof.
    Type: Grant
    Filed: October 25, 2016
    Date of Patent: March 12, 2019
    Assignee: Jiangsu Kanion Pharmaceutical Co. Ltd
    Inventors: Peng Li, Bailing Yang, Fei Hao, Zheng Wang, Zongbin Li, Haiying He, Shuhui Chen, Wei Xiao, Wang Shen, Zhenzhong Wang
  • PYRIDO[1,2-A]PYRIMIDONE ANALOG, CRYSTAL FORM THEREOF, INTERMEDIATE THEREOF AND PREPARATION METHOD THEREFOR
    Publication number: 20180319799
    Abstract: Disclosed in the present invention are a crystalline Form of pyrido[1,2-a]pyrimidone analog, a preparation method therefor and an intermediate thereof,
    Type: Application
    Filed: December 16, 2016
    Publication date: November 8, 2018
    Inventors: Tao Yu, Ning Li, Lingwei Kong, Peipei Jiang, Yong Wang, Zhemin Rong, Changjun Wang, Feng Guo, Zongbin Li, Zheng Wang, Jiahu Wu, Chengde Wu
  • CRYSTAL FORM, PREPARATION METHOD AND INTERMEDIATE OF DIHYDROPYRIDO RING COMPOUND
    Publication number: 20180312512
    Abstract: Disclosed in the present disclosure are a crystal form of a dihydropyrido ring compound, and preparation method and intermediate thereof.
    Type: Application
    Filed: November 2, 2016
    Publication date: November 1, 2018
    Inventors: Haiying HE, Kai ZHOU, Xiaolin LI, Xiaofei WANG, Dakun QIN, Xingxing WANG, Feifei YANG, Zheng WANG, Zongbin LI
  • SALT FORM AND CRYSTAL FORM OF 1,2,5-THIADIAZOLIDIN-1,1-DIOXIDE, PREPARATION METHOD THEREOF AND INTERMEDIATE
    Publication number: 20180141940
    Abstract: The present invention discloses a salt form, crystal form and intermediate of the compound 1, and preparation method thereof.
    Type: Application
    Filed: October 25, 2016
    Publication date: May 24, 2018
    Inventors: Peng LI, Bailing YANG, Fei HAO, Zheng WANG, Zongbin LI, Haiying HE, Shuhui CHEN, Wei XIAO, Wang SHEN, Zhenzhong WANG